GSK · SUB~ · BR · GLAXO-SMITHKLINE BIOLOGICALS MANUFACTURING S.A

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE BIOLOGICALS ~0.76' «GLAXO-SMITHKLINE BIOLOGICALS MANUFACTURING S.A» ↔ SEC GSK (CIK 1131399, GSK plc): 7 non-competitive contracts at the buyer «FUNDACAO OSWALDO CRUZ», 723,816,444 BRL (≈ $130,286,960); method direct (tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modalidadeId: 8; modalidadeNome: Dispensa; modoDisputaId: 5; modoDisputaNom; OCID ocds-ye9ov3-33781055000135_2025_1761, ocds-ye9ov3-33781055000135_2025_260, ocds-ye9ov3-33781055000135_2025_855, ocds-914jxj-25444506002052024, ocds-914jxj-25444506001122025, ocds-914jxj-25444506003452025, ocds-914jxj-25444507002342025.

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject

GSK · SUB~ · BR · GLAXO-SMITHKLINE BIOLOGICALS MANUFACTURING S.A

Indicator

Debarred / sanctioned abroad × US SEC issuer

Amount

130,286,960

Records behind the indicator

7

Found

4 October 2026

Code

W-00132

Reference

ocds-ye9ov3-33781055000135_2025_1761

Reference

ocds-ye9ov3-33781055000135_2025_260

Reference

ocds-ye9ov3-33781055000135_2025_855

Reference

ocds-914jxj-25444506002052024

Reference

ocds-914jxj-25444506001122025

Reference

ocds-914jxj-25444506003452025

Reference

ocds-914jxj-25444507002342025